Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia

Some research suggests that blood–brain barrier (BBB) integrity is altered in Alzheimer's disease (AD). Few studies have examined markers of BBB integrity and their interactions with AD risk factors on multi‐domain cognition.

• Publication year

  2025

• Venue

  Alzheimer's & Dementia

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/alz.70910PMID 41216906PMCID 12603782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disorders

  2025influential reference
• Pathological angiogenesis was associated with cerebrovascular lesion and neurodegeneration in Alzheimer's disease

  2025influential reference
• Cerebral hypoperfusion, brain structural integrity, and cognitive impairment in older APOE4 carriers

  2025cited by this paper
• Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease

  2024cited by this paper
• Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease

  2024cited by this paper
• Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease

  2024cited by this paper
• Evidence of Pericyte Damage in a Cognitively Normal Cohort

  2024cited by this paper
• Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.

  2024cited by this paper
• Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles

  2024cited by this paper
• Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation

  2024cited by this paper
• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

  2024cited by this paper
• Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions

  2023cited by this paper
• Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease

  2023cited by this paper
• sPDGFRβ and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study

  2023cited by this paper
• Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes

  2023cited by this paper
• Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers

  2022cited by this paper
• FDA Clears First In Vitro Assay to Improve Alzheimer’s Diagnosis

  2022cited by this paper
• Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease

  2021cited by this paper
• Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia

  2021influential reference
• Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage

  2020cited by this paper
• APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline

  2020cited by this paper
• A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid

  2020cited by this paper
• Alzheimer’s Disease and Vascular Aging

  2020cited by this paper
• Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid

  2020cited by this paper
• Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer’s Disease

  2020cited by this paper
• Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline

  2020cited by this paper
• Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease

  2019cited by this paper
• CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

  2019influential reference
• The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease

  2019cited by this paper
• Blood-Brain Barrier: From Physiology to Disease and Back.

  2019cited by this paper
• Vascular dysfunction—The disregarded partner of Alzheimer's disease

  2019cited by this paper
• Pericytes and Neurovascular Function in the Healthy and Diseased Brain

  2019cited by this paper
• Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism

  2018cited by this paper
• Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction

  2018influential reference
• Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study

  2018cited by this paper
• Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

  2017cited by this paper
• NPTX2 and cognitive dysfunction in Alzheimer’s Disease

  2017cited by this paper
• sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

  2016cited by this paper
• Pulse Pressure Is Associated With Early Brain Atrophy and Cognitive Decline: Modifying Effects of APOE-&egr;4

  2016cited by this paper
• Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

  2016cited by this paper
• Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study

  2016cited by this paper
• CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD.

  2016cited by this paper
• Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes.

  2015cited by this paper
• Blood-brain barrier breakdown in the aging human hippocampus.

  2015influential reference
• Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment

  2015cited by this paper
• Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy‐confirmed Alzheimer's disease

  2015cited by this paper
• Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

  2014cited by this paper
• Neuropsychological Syndromes Associated with Alzheimer's/Vascular Dementia: A Latent Class Analysis

  2014cited by this paper
• The neurovascular unit – concept review

  2014cited by this paper
• Cerebral Blood Flow Measured by Arterial Spin Labeling MRI as a Preclinical Marker of Alzheimer's Disease

  2014cited by this paper
• Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review

  2014cited by this paper
• Amyloid‐β efflux from the central nervous system into the plasma

  2014cited by this paper
• APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.

  2013cited by this paper
• Interaction of Age and APOE Genotype on Cerebral Blood Flow at Rest

  2013cited by this paper
• Assessment of Alzheimer's Disease Risk with Functional Magnetic Resonance Imaging: An Arterial Spin Labeling Study

  2012cited by this paper
• Overview and introduction: The blood–brain barrier in health and disease

  2012cited by this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011cited by this paper
• Endothelin and the neurovascular unit in pediatric traumatic brain injury

  2011cited by this paper
• Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

  2010cited by this paper
• Elevated pulse pressure is associated with age-related decline in language ability

  2010cited by this paper
• Pericyte-Mediated Regulation of Capillary Diameter: A Component of Neurovascular Coupling in Health and Disease

  2010cited by this paper
• The Dysexecutive Syndrome Associated with Ischaemic Vascular Disease and Related Subcortical Neuropathology: A Boston Process Approach

  2010cited by this paper
• Cerebral perfusion and oxygenation differences in Alzheimer's disease risk.

  2009cited by this paper
• A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain

  2008cited by this paper
• Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease

  2008cited by this paper
• Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.

  2007cited by this paper
• Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease

  2007cited by this paper
• Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease

  2006cited by this paper
• Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

  2006cited by this paper
• Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.

  2006cited by this paper
• Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

  1999cited by this paper
• Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

  1998cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Working memory and the Self-Ordered Pointing Task: further evidence of early prefrontal decline in normal aging.

  1993cited by this paper
• Short-term longitudinal change in cognitive performance in later life.

  1992cited by this paper

• Adiponectin Inhibits Oxidative Stress and Tight Junction Protein Loss: Evidence from a Hepatic Encephalopathy Mouse Model and Brain Endothelial Cells

  2026cites this paper